Potential explanations include differences in the type of patients included, adherence to study treatment, sample size, duration of drug exposure, and GLP1 receptor activation with greater HbA1c reduction with longer-acting human GLP1-based analogs than with some short-acting exendin-4 analogs
In a lab environment where multiple compounds may be in circulation at once, an unlabeled vial isnt just inconvenient its a research validity risk, since theres no way to confirm identity or freshness after the fact
People describe a simultaneous shift in their relationship with both food and alcohol
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management and subsequently approved for chronic weight management
Last reviewed: June 28, 2026 Last updated: June 28, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations